Christian Mandl
Fondateur chez Tiba Biotech LLC
Postes actifs de Christian Mandl
Sociétés | Poste | Début | Fin |
---|---|---|---|
Adjuvant Capital LP
Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | Consultant / Advisor | 01/09/2019 | - |
Tiba Biotech LLC
Tiba Biotech LLC BiotechnologyHealth Technology Tiba Biotech LLC is a company that specializes in advancing the RNA medicine field with an improved approach to nucleic acid delivery. The company is based in Cambridge, MA. The company has developed a fully biodegradable nanoparticle delivery platform for safer vaccines and therapeutics, as well as a computational RNA design for more potent gene expression. The company's goal is to achieve better patient outcomes through rational design, from gene to delivery method beyond vaccines. The company was founded in 2017 by Christian Mandl, Karl H. Ruping, Jasdave Chahal. Karl H. Ruping has been the CEO since 2017. | Fondateur | 01/03/2018 | - |
International Vaccine Institute
International Vaccine Institute Miscellaneous Commercial ServicesCommercial Services The International Vaccine Institute develops and distributes vaccines. The non-profit company is based in Seoul, South Korea. Jerome H. Kim has been the CEO of the South Korean company since 2015. | Consultant / Advisor | 01/09/2018 | - |
Corporate Officer/Principal | 01/09/2018 | - |
Historique de carrière de Christian Mandl
Anciens postes connus de Christian Mandl
Sociétés | Poste | Début | Fin |
---|---|---|---|
Themis Bioscience GmbH
Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Président | 01/01/2016 | 01/06/2020 |
Consultant / Advisor | 01/01/2016 | 01/06/2020 | |
VIR BIOTECHNOLOGY, INC. | Private Equity Investor | 01/01/2017 | 31/12/2017 |
NOVARTIS AG | Private Equity Investor | 01/04/2008 | 30/04/2014 |
Medical University of Vienna | Corporate Officer/Principal | 01/01/2004 | 01/04/2008 |
Formation de Christian Mandl
University of Vienna | Doctorate Degree |
The Pennsylvania State University | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Autriche | 4 |
Suisse | 2 |
Opérationnelle
Consultant / Advisor | 3 |
Private Equity Investor | 2 |
Corporate Officer/Principal | 2 |
Sectorielle
Health Technology | 5 |
Consumer Services | 4 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
VIR BIOTECHNOLOGY, INC. | Health Technology |
NOVARTIS AG | Health Technology |
Entreprise privées | 4 |
---|---|
Adjuvant Capital LP
Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | Finance |
Tiba Biotech LLC
Tiba Biotech LLC BiotechnologyHealth Technology Tiba Biotech LLC is a company that specializes in advancing the RNA medicine field with an improved approach to nucleic acid delivery. The company is based in Cambridge, MA. The company has developed a fully biodegradable nanoparticle delivery platform for safer vaccines and therapeutics, as well as a computational RNA design for more potent gene expression. The company's goal is to achieve better patient outcomes through rational design, from gene to delivery method beyond vaccines. The company was founded in 2017 by Christian Mandl, Karl H. Ruping, Jasdave Chahal. Karl H. Ruping has been the CEO since 2017. | Health Technology |
Themis Bioscience GmbH
Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Health Technology |
International Vaccine Institute
International Vaccine Institute Miscellaneous Commercial ServicesCommercial Services The International Vaccine Institute develops and distributes vaccines. The non-profit company is based in Seoul, South Korea. Jerome H. Kim has been the CEO of the South Korean company since 2015. | Commercial Services |
- Bourse
- Insiders
- Christian Mandl
- Expérience